Chesley Taft & Associates’s VistaGen Therapeutics VTGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-667
| Closed | -$2.49K | – | 297 |
|
|
2023
Q1 | $2.49K | Hold |
667
| – | – | ﹤0.01% | 286 |
|
|
2022
Q4 | $2.06K | Hold |
667
| – | – | ﹤0.01% | 284 |
|
|
2022
Q3 | $3K | Hold |
667
| – | – | ﹤0.01% | 279 |
|
|
2022
Q2 | $18K | Hold |
667
| – | – | ﹤0.01% | 286 |
|
|
2022
Q1 | $28K | Hold |
667
| – | – | ﹤0.01% | 293 |
|
|
2021
Q4 | $39K | Hold |
667
| – | – | ﹤0.01% | 298 |
|
|
2021
Q3 | $55K | Hold |
667
| – | – | ﹤0.01% | 296 |
|
|
2021
Q2 | $63K | Hold |
667
| – | – | ﹤0.01% | 292 |
|
|
2021
Q1 | $46K | Buy |
+667
| New | +$46K | ﹤0.01% | 286 |
|